209 related articles for article (PubMed ID: 12231078)
21. The role of glimepiride in the effective management of Type 2 diabetes.
Davis SN
J Diabetes Complications; 2004; 18(6):367-76. PubMed ID: 15531188
[TBL] [Abstract][Full Text] [Related]
22. Insulin sensitizers.
Zangeneh F; Kudva YC; Basu A
Mayo Clin Proc; 2003 Apr; 78(4):471-9. PubMed ID: 12683699
[TBL] [Abstract][Full Text] [Related]
23. [Combination therapy with biguanides].
Sakura H
Nihon Rinsho; 2002 Oct; 60 Suppl 10():724-8. PubMed ID: 12430309
[No Abstract] [Full Text] [Related]
24. Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus.
Modi P
Curr Drug Discov Technol; 2007 Jun; 4(1):39-47. PubMed ID: 17630927
[TBL] [Abstract][Full Text] [Related]
25. [Clinical difference between thiazolidinediones and biguanides].
Hotta N
Nihon Rinsho; 2001 Nov; 59(11):2219-27. PubMed ID: 11712411
[TBL] [Abstract][Full Text] [Related]
26. Oral pharmacologic management of type 2 diabetes.
Riddle MC
Am Fam Physician; 1999 Dec; 60(9):2613-20. PubMed ID: 10605995
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacologic treatment of diabetes].
De Montigny P; Clerc C; Descarpentries C
Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094
[No Abstract] [Full Text] [Related]
28. Oral antihyperglycemic therapy for type 2 diabetes: clinical applications.
Holmboe ES
JAMA; 2002 Jan; 287(3):373-6. PubMed ID: 11790217
[TBL] [Abstract][Full Text] [Related]
29. A comparison of agents used to manage type 2 diabetes mellitus: need for reappraisal of traditional approaches.
Bell DS
Treat Endocrinol; 2004; 3(2):67-76. PubMed ID: 15743102
[TBL] [Abstract][Full Text] [Related]
30. [Diabetes mellitus].
Kawano M; Kanazawa Y
Nihon Rinsho; 2000 Feb; 58(2):421-5. PubMed ID: 10707569
[TBL] [Abstract][Full Text] [Related]
31. Oral combination therapy for type 2 diabetes.
Charpentier G
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S70-6. PubMed ID: 12324989
[TBL] [Abstract][Full Text] [Related]
32. Insulin action enhancers for the management of type 2 diabetes mellitus.
Valsamakis G; Kumar S
Expert Opin Pharmacother; 2000 Dec; 1(7):1413-21. PubMed ID: 11249474
[TBL] [Abstract][Full Text] [Related]
33. Insulin in the early management of diabetic complications.
Miles JM
J Assoc Physicians India; 2003 May; 51():501-5. PubMed ID: 12974435
[TBL] [Abstract][Full Text] [Related]
34. Targeted glycemic control in type 2 diabetes.
Skyler JS
J Fla Med Assoc; 1998 Aug; 85(2):7-15. PubMed ID: 9782713
[No Abstract] [Full Text] [Related]
35. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
Standl E; Schnell O
Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
[No Abstract] [Full Text] [Related]
36. [Oral antidiabetic agents including glucosidase inhibitors].
Raptis S
Internist (Berl); 1987 Apr; 28(4):243-53. PubMed ID: 3298124
[No Abstract] [Full Text] [Related]
37. Oral antihyperglycemic therapy for type 2 diabetes mellitus.
Cheng AY; Fantus IG
CMAJ; 2005 Jan; 172(2):213-26. PubMed ID: 15655244
[TBL] [Abstract][Full Text] [Related]
38. Pioglitazone and sulfonylureas: effectively treating type 2 diabetes.
Hanefeld M
Int J Clin Pract Suppl; 2007 Jun; 61(153):20-7. PubMed ID: 17594390
[TBL] [Abstract][Full Text] [Related]
39. [Pharmacotherapies for type 1 diabetes mellitus].
Maruyama T
Nihon Rinsho; 2002 Sep; 60 Suppl 9():190-5. PubMed ID: 12386992
[No Abstract] [Full Text] [Related]
40. Oral antihyperglycemic agents during pregnancy and lactation: a review.
Merlob P; Levitt O; Stahl B
Paediatr Drugs; 2002; 4(11):755-60. PubMed ID: 12390047
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]